Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypothalamic Obesity

Interventions

DRUG: Setmelanotide

Sponsor

Rhythm Pharmaceuticals, Inc.